Related references
Note: Only part of the references are listed.Methods and role of minimal residual disease after stem cell transplantation
Marco Ladetto et al.
BONE MARROW TRANSPLANTATION (2019)
High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia
Mingshan Niu et al.
CANCER CELL INTERNATIONAL (2019)
High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
Huihui Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
Juliane Grimm et al.
BONE MARROW TRANSPLANTATION (2019)
Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia
Yiqun Huang et al.
CANCER BIOMARKERS (2018)
MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia
Stefania Trino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia
Raj Bhayadia et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
Qiu-Ling Ma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Abnormal microRNA expression in the course of hematological malignancies
Agnieszka Szymczyk et al.
CANCER MANAGEMENT AND RESEARCH (2018)
MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy
Chen Yang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
HOX genes in normal, engineered and malignant hematopoiesis
Emma M. Collins et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations
Mingshan Niu et al.
ANNALS OF HEMATOLOGY (2017)
MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts
Jared A. Wallace et al.
BLOOD (2017)
Therapeutic targeting of acute myeloid leukemia stem cells
Daniel A. Pollyea et al.
BLOOD (2017)
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
David Grimwade et al.
BLOOD (2016)
MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia
D. C. de Leeuw et al.
LEUKEMIA (2016)
Expression of a passenger miR-9*predicts favorable outcome in adults with acute myeloid leukemia less than 60 years of age
K. Nowek et al.
LEUKEMIA (2016)
When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia
Markus Ball et al.
BLOOD (2016)
Clinical significance of microRNAs in chronic and acute human leukemia
Chien-Hung Yeh et al.
MOLECULAR CANCER (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS
Danilo Fiore et al.
ONCOTARGET (2016)
Disease evolution and outcomes in familial AML with germline CEBPA mutations
Kiran Tawana et al.
BLOOD (2015)
The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia
Hidemasa Matsuo et al.
HAEMATOLOGICA (2015)
Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report
Fabiana Ostronoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells
D. H. Spencer et al.
LEUKEMIA (2015)
The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia
Hidemasa Matsuo et al.
HAEMATOLOGICA (2015)
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
J. J. Cornelissen et al.
LEUKEMIA (2015)
miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer
S. Fernandez et al.
ONCOGENE (2015)
Mixed lineage leukaemia histone methylases 1 collaborate with ERα to regulate HOXA10 expression in AML
Jie Yao et al.
BIOSCIENCE REPORTS (2014)
Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia
Jeffery M. Klco et al.
CANCER CELL (2014)
Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML
S. M. Sun et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia
Ann-Kathrin Eisfeld et al.
BLOOD (2012)
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
Zejuan Li et al.
NATURE COMMUNICATIONS (2012)
miR-340 Inhibition of Breast Cancer Cell Migration and Invasion Through Targeting of Oncoprotein c-Met
Zheng-sheng Wu et al.
CANCER (2011)
Leukemogenic transformation by HOXA cluster genes
Christian Bach et al.
BLOOD (2010)
Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Sebastian Schwind et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML
Mike Zangenberg et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Hox genes in hematopoiesis and leukemogenesis
B. Argiropoulos et al.
ONCOGENE (2007)
Share Paper
